CYTOKINETICS INC's ticker is CYTK and the CUSIP is 23282W605. A total of 131 filers reported holding CYTOKINETICS INC in Q3 2017. The put-call ratio across all filers is 0.86 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $610,000 | -30.5% | 84,690 | -21.4% | 0.08% | -31.0% |
| Q4 2017 | $878,000 | -23.1% | 107,728 | +36.8% | 0.12% | -25.2% |
| Q3 2017 | $1,142,000 | +102.8% | 78,758 | +69.3% | 0.16% | +91.4% |
| Q2 2017 | $563,000 | +50.9% | 46,529 | +60.3% | 0.08% | +39.7% |
| Q1 2017 | $373,000 | – | 29,019 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 223,382 | $7,286,721 | 8.83% |
| Saturn V Capital Management LP | 406,225 | $13,251,060 | 7.35% |
| Logos Global Management LP | 1,650,000 | $53,823,000 | 7.32% |
| Finepoint Capital LP | 369,093 | $12,039,814 | 4.16% |
| GREAT POINT PARTNERS LLC | 600,000 | $19,572,000 | 3.83% |
| Boxer Capital, LLC | 2,100,000 | $68,502 | 3.18% |
| PFM Health Sciences, LP | 2,399,545 | $78,273,158 | 3.04% |
| DAFNA Capital Management LLC | 332,734 | $10,853,783 | 2.97% |
| Integral Health Asset Management, LLC | 650,000 | $21,203,000 | 2.62% |
| Sofinnova Investments, Inc. | 843,228 | $27,506,097 | 1.80% |